Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166140 · ClinicalTrials.gov registry record
Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 125
- Enrollment target
NCT00166140 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 125 participants.
The verdict
NCT00166140 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Heparin is an anticoagulant or "blood thinner". Heparin is always given to patients undergoing open-heart surgery to prevent blood from clotting when a patient is placed on the heart-lung machine. Heparin works by combining with a protein in blood to prevent other proteins from working together to form a clot. The protein that heparin combines with seems to be different in infants and young children compared to adults. The purpose of this study is to determine which proteins in children have a direct impact on the way heparin works. We also want to see how this may change at different ages. We will enroll two age groups of children; birth to 2 years and 10 years or older. A total of 125 patients will be enrolled into this study. These patients will already be scheduled for open-heart surgery using a heart-lung machine. The testing involves taking blood samples when the patient is asleep for surgery; and later from their intravenous line, IV. They will all have IV's in place already because of the surgery. Therefore the study will cause no pain or discomfort for the patients who take part.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2002-12 |
| Est. Completion | 2006-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166140
The ClinicalTrials.gov registry entry for NCT00166140 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00166140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166140 about?
NCT00166140 is a clinical study titled "Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.". Heparin is an anticoagulant or "blood thinner". Heparin is always given to patients undergoing open-heart surgery to prevent blood from clotting when a patient is placed on the heart-lung machine. Heparin works by combining with a protein in blood to prevent other proteins from working together to f...
What is the current status of trial NCT00166140?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2002-12. Estimated completion is 2006-05.
Who is sponsoring clinical trial NCT00166140?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.